Search for: "MERRELL"
Results 481 - 500
of 602
Sorted by Relevance
|
Sort by Date
23 Jan 2014, 9:37 am
Merrell Dow Pharmaceuticals, Inc. [read post]
21 Sep 2009, 3:23 am
Merrell Dow Pharms., 509 U.S. 579, 591 (1993) (holding that evidence is relevant if it may assist the trier of fact in resolving a factual dispute); Moleculon, 793 F.2d at 1272. [read post]
4 Oct 2021, 8:17 am
Merrell Dow Pharms., Inc., 509 U.S. 579,587 (1993). [3] Frye v. [read post]
8 Feb 2011, 11:47 am
Merrell Dow Pharms., Inc., 509 U.S. 579, 588-91 (1993). [read post]
19 Sep 2008, 8:13 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
26 Oct 2013, 4:16 pm
Robert Brent, a toxicologist, who appears to her as Merrell Dow’s expert witness “always ready to testify that Bendectin does not cause birth defects. [read post]
24 Jun 2015, 7:27 pm
Although Merrell Richardson funded some studies early on, by the time the scientific consensus emerged, many studies funded by neutral sources, and conducted by researchers of respected integrity, were widely available. [read post]
10 Sep 2014, 9:00 am
Merrell Dow Pharmaceuticals regarding important expert testimony requires the appellate court to order a new trial, regardless of whether there was actually any substantive error in the expert testimony heard or not heard by the jury. [read post]
27 Feb 2024, 12:07 pm
Antic proposals abound in the legal analysis of expert witness opinion evidence. [read post]
29 Mar 2024, 8:22 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [6] General Electric Co. v. [read post]
3 Apr 2024, 4:08 pm
Merrell Dow Pharms., Inc., 509 U.S. 579, 593-594 (1993). [2] Id. at 594 (internal citations omitted) (emphasis added). [3] Id [read post]
8 Aug 2011, 5:16 am
Merrell Dow Pharm., Inc., 509 U.S. 579, 589 (1993). [read post]
9 May 2022, 5:01 am
Merrell Dow Pharms., Inc. (1993), the Supreme Court explained that Rule 702 imposes an obligation on a trial court to act as a gatekeeper to ensure that any and all scientific [or otherwise specialized] testimony or evidence admitted is not only relevant, but reliable. [read post]
29 Jul 2017, 12:34 pm
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), and which did involve any Rule 702 challenge to the use of a flawed statistical analysis. [read post]
18 Oct 2011, 7:14 am
Merrell Dow Pharms., Inc., 911 F.2d 941, 958 (3d Cir. 1990); cf. [read post]
8 Apr 2022, 3:36 am
Merrell, MBA, ACP, has been a real estate and finance paralegal for over 20 years. [read post]
7 Feb 2007, 4:08 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as “gatekeepers” concerning the admissibility of evidence - does not apply at the class certification stage. [read post]
7 May 2022, 5:01 am
Merrell Dow Pharmaceuticals, Inc. [read post]
13 Jun 2017, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
14 Oct 2011, 1:55 pm
Merrell Dow Pharms., Inc., 911 F.2d 941, 958 (3d Cir. 1990); cf. [read post]
